Over 5 million people die each year from viral diseases.
2 billion people lack access to essential medicines.
Only 1% of new drugs developed in the last 30 years target neglected diseases.
The International Consortium on Anti-Virals (ICAV) is a not-for-profit drug development organization dedicated to the discovery and development of anti-viral therapies for neglected and emerging diseases.
ICAV’s goal is to deliver one drug to market every five years that is affordable, effective, and accessible to all patients in need.
H1N1 Resource and Updates
A new ICAV site for Influenza H1N1 virus: background, updates and discoveries
News
June 2, 2010
Ontario’s Response To H1n1 Pandemic
Full article
[ More news…]
News from the World Health organization
| Thu, 29 Jul 2010 10:00:00 GMT |
| Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO |
| Full text |
| Thu, 29 Jul 2010 09:00:00 GMT |
| Avian influenza - situation in Egypt - update 35 |
| Full text |
| Thu, 22 Jul 2010 10:00:00 GMT |
| Avian influenza – situation in Indonesia - update 2 |
| Full text |
| Thu, 22 Jul 2010 10:00:00 GMT |
| Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO |
| Full text |











